Trimetazidine improves myocardial perfusion and left ventricular function in ischemic left ventricular dysfunction.
Feola
Mauro
M
Department of Cardiovascular Diseases, Ospedale S Croce e Carle, Cuneo, Italy. m_feola@virgilio.it
Biggi
Alberto
A
Francini
Antonella
A
Leonardi
Giovanni
G
Ribichini
Flavio
F
Ferrero
Valeria
V
Uslenghi
Eugenio
E
D000368:Aged; D003324:Coronary Artery Disease / Q000150:complications / Q000000981:diagnostic imaging* / Q000188:drug therapy*; D003331:Coronary Vessels / Q000000981:diagnostic imaging*; D015637:Gated Blood-Pool Imaging; D006352:Heart Ventricles / Q000000981:diagnostic imaging; D006801:Humans; D008297:Male; D009203:Myocardial Infarction / Q000000981:diagnostic imaging* / Q000188:drug therapy* / Q000209:etiology; D017202:Myocardial Ischemia / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000209:etiology; D016037:Single-Blind Method; D013318:Stroke Volume; D016896:Treatment Outcome; D014292:Trimetazidine / Q000627:therapeutic use*; D014665:Vasodilator Agents / Q000627:therapeutic use; D018487:Ventricular Dysfunction, Left / Q000000981:diagnostic imaging* / Q000188:drug therapy* / Q000209:etiology
D014665:Vasodilator Agents; D014292:Trimetazidine